Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells
- PMID: 16153159
- DOI: 10.1089/dna.2005.24.582
Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells
Abstract
Overexpression of the ERBB2 gene occurs in 30% of human breast cancers and is correlated with poor prognosis. The deregulation is the consequence of an increased transcription level and gene amplification. Several laboratories, including our own, have identified, in the proximal promoter, enhancers implicated in the gene overexpression. However, our previous studies of a 6-kb ERBB2 promoter fragment revealed the presence of repressing fragments, which were able to overcome the effect of the proximal enhancers. These repressing elements were functional in all cell lines, regardless of their endogenous ERBB2 expression level. Here, we show that a distal ERBB2 promoter region restores high transcription rates specifically in ERBB2 overexpressing breast cancer cells. This distal promoter region thus contains enhancers essential for the overexpression of the gene. By EMSA, performed with nuclear extract of cells overexpressing (BT-474) or not (MDA-MB-231) the ERBB2 gene, we show that at least two sequences of the distal promoter region are bound exclusively by BT-474 extract. Further experiments reveal that AP-2 transcription factors contribute to this differential binding activity, by binding recognition sequences located 4500 bp and 4000 bp upstream of the transcription start site. These sites are occupied by AP2 in vivo, as demonstrated by ChIP assay. Inactivation of AP-2 proteins in ERBB2 overexpressing cells reduces the distal promoter activity up to 70%, indicating the AP-2 factors are implicated in the strong distal enhancing effect. Moreover, we identified a 54-bp fragment that is bound specifically by BT-474 nuclear extract. Further experiments did not lead to the identification of the protein responsible for this binding. Our results thus highlight the importance of ERBB2 distal promoter region and further implicate AP-2 in ERBB2 overexpression in breast cancer cells.
Similar articles
-
Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells.J Biol Chem. 2005 Jul 1;280(26):24428-34. doi: 10.1074/jbc.M503790200. Epub 2005 May 3. J Biol Chem. 2005. PMID: 15870067
-
Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.Breast Cancer Res. 2009;11(6):R83. doi: 10.1186/bcr2450. Epub 2009 Nov 11. Breast Cancer Res. 2009. PMID: 19906305 Free PMC article.
-
Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression.Biochem J. 2003 Feb 15;370(Pt 1):323-9. doi: 10.1042/BJ20021238. Biochem J. 2003. PMID: 12418962 Free PMC article.
-
Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment.Breast Cancer Res. 2001;3(6):395-8. doi: 10.1186/bcr329. Epub 2001 Oct 1. Breast Cancer Res. 2001. PMID: 11737892 Free PMC article. Review.
-
Hormonal regulation of type I receptor tyrosine kinase expression in the mammary gland.J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):175-85. doi: 10.1023/a:1026308015763. J Mammary Gland Biol Neoplasia. 1997. PMID: 10882303 Review.
Cited by
-
Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.Oncogene. 2016 Apr 28;35(17):2208-22. doi: 10.1038/onc.2015.281. Epub 2015 Jul 27. Oncogene. 2016. PMID: 26212010
-
ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism.Oncol Rep. 2013 Mar;29(3):1161-6. doi: 10.3892/or.2012.2186. Epub 2012 Dec 14. Oncol Rep. 2013. PMID: 23242156 Free PMC article.
-
The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis.Oncogene. 2015 Dec 10;34(50):6105-14. doi: 10.1038/onc.2015.59. Epub 2015 Mar 16. Oncogene. 2015. PMID: 25772240 Free PMC article.
-
PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.Biochim Biophys Acta. 2012 Jan;1819(1):1-15. doi: 10.1016/j.bbagrm.2011.09.006. Epub 2011 Oct 7. Biochim Biophys Acta. 2012. PMID: 22001530 Free PMC article.
-
Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.Oncogene. 2013 Aug 22;32(34):4043-51. doi: 10.1038/onc.2012.400. Epub 2012 Sep 10. Oncogene. 2013. PMID: 22964634 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous